Profile data is unavailable for this security.
About the company
Emyria Limited is an Australia-based clinical services and drug development company. The Company is focused on developing patient outcomes in neuroscience and mental health through its clinical service delivery, proprietary real-world data (RWD), and drug discovery & development. It delivers evidence-based and emerging therapies for mental health and other unmet needs through its Emerald Clinics and the Pax Centre. Emerald Clinics specializes in providing treatments for patients with complex and chronic conditions. The Pax Centre specializes in treating individuals grappling with the psychological impacts of traumatic experiences. Through its advanced data platform operated by Palantir, the Company collects robust and ethically sourced real-world data to improve its care models and support its distinct therapy and drug development initiatives. The Company is also developing several proprietary ultra-pure cannabinoid dose forms and advancing them towards registration, such as EMD-RX5.
- Revenue in AUD (TTM)1.95m
- Net income in AUD-11.95m
- Incorporated2018
- Employees--
- LocationEmyria LtdD2 661 Newcastle StreetLEEDERVILLE 6007AustraliaAUS
- Phone+61 86559-2800
- Fax+61 86559-2829
- Websitehttps://www.emeraldclinics.com.au/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Genetic Technologies Ltd | 8.49m | -12.71m | 6.40m | 60.00 | -- | 1.06 | -- | 0.7536 | -0.1126 | -0.1126 | 0.0752 | 0.0417 | 0.7028 | 9.84 | 4.20 | 141,514.20 | -105.21 | -52.85 | -154.00 | -61.70 | 53.55 | 49.50 | -149.69 | -247.36 | 1.55 | -- | 0.0736 | -- | 27.83 | 114.96 | -64.79 | -- | 49.00 | -- |
| Emyria Ltd | 1.95m | -11.95m | 18.00m | -- | -- | 16.98 | -- | 9.23 | -0.0363 | -0.0363 | 0.0062 | 0.0026 | 0.275 | -- | 49.60 | -- | -168.58 | -77.78 | -321.66 | -93.49 | -12.45 | -45.04 | -612.98 | -388.17 | -- | -30.01 | 0.7573 | -- | -12.62 | -- | 29.98 | -- | -- | -- |
| Artrya Ltd | 0.00 | -11.56m | 24.40m | -- | -- | 1.03 | -- | -- | -0.1472 | -0.1472 | 0.00 | 0.3021 | 0.00 | -- | -- | -- | -36.17 | -- | -38.11 | -- | -- | -- | -- | -- | -- | -- | 0.0435 | -- | -- | -- | 35.09 | -- | -- | -- |
| Cleo Diagnostics Ltd | 302.22k | -3.92m | 24.89m | -- | -- | 3.72 | -- | 82.35 | -0.0305 | -0.0305 | 0.0024 | 0.082 | 0.0502 | -- | 3.76 | -- | -65.13 | -- | -76.78 | -- | -- | -- | -1,296.85 | -- | -- | -28.11 | 0.00 | -- | -- | -- | -3,836.95 | -- | -- | -- |
| Cryosite Ltd | 12.61m | 1.58m | 47.35m | 34.00 | 30.07 | 16.35 | 20.42 | 3.75 | 0.0323 | 0.0323 | 0.2582 | 0.0593 | 0.5912 | 74.83 | 7.30 | -- | 7.39 | 4.12 | 8.99 | 4.88 | 60.85 | 53.88 | 12.50 | 8.56 | 2.29 | -- | 0.4487 | -- | 1.51 | 15.04 | 3.30 | -- | 10.72 | -- |
| Apiam Animal Health Ltd | 202.40m | 2.66m | 65.32m | -- | 24.54 | 0.5285 | 4.73 | 0.3227 | 0.0147 | 0.0147 | 1.13 | 0.6811 | 0.8095 | 3.81 | 12.48 | -- | 1.03 | 2.44 | 1.40 | 2.93 | 64.92 | 57.66 | 1.27 | 2.70 | 0.603 | 1.77 | 0.4653 | 48.88 | 22.09 | 12.46 | -50.92 | -7.03 | 10.86 | -- |
| Microba Life Sciences Ltd | 6.54m | -18.49m | 89.57m | -- | -- | 1.82 | -- | 13.69 | -0.0502 | -0.0502 | 0.0178 | 0.11 | 0.1119 | 2.67 | 9.26 | -- | -31.64 | -- | -37.61 | -- | 46.55 | -- | -282.64 | -- | 3.11 | -- | 0.0272 | -- | 15.60 | -- | -10.55 | -- | -- | -- |
